Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Harold Hoffman

Allergy & Immunology San Diego, CA Medical Doctor

NPI 1326074261 CMS profile 331636

8110 Birmingham Way, Bldg 28, San Diego, CA 92123

Open in the dashboard

General payments

$75,727

200 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Harold Hoffman of San Diego, CA is reported in the CMS Open Payments database as having received $75,727 across 200 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,532 45
2024 General $21,294 32
2023 General $4,791 31
2022 General $7,239 30
2021 General $1,598 21
2020 General $10,948 12
2019 General $13,324 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Harold Hoffman
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Harold Hoffman were reported at $16,532. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year Harold Hoffman Allergy & Immunology median Middle half National median
2019 $13,324 $594 $163–$1,512 $163
2020 $10,948 $426 $106–$1,233 $114
2021 $1,598 $638 $157–$1,708 $132
2022 $7,239 $790 $205–$1,961 $149
2023 $4,791 $852 $220–$2,147 $160
2024 $21,294 $865 $203–$2,267 $164
2025 $16,532 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $23,240 26 payments
  2. Swedish Orphan Biovitrum AB $20,125 2 payments
  3. Pharming Healthcare, Inc. $9,024 18 payments
  4. Amgen Inc. $6,932 9 payments
  5. Sobi, Inc $3,614 7 payments
  6. Astellas Pharma Inc $3,600 2 payments
  7. AbbVie, Inc. $2,286 4 payments
  8. AstraZeneca Pharmaceuticals LP $699 6 payments
  9. Grifols USA, LLC $689 21 payments
  10. GlaxoSmithKline, LLC. $531 9 payments
  11. Other $4,988 96 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $35,364 14 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,219 7 payments
  3. Travel and Lodging $14,224 7 payments
  4. Food and Beverage $8,921 172 payments
Products named General payments · program years 2019–2025
  1. ILARIS Immunology $11,965 9 payments
  2. ILARIS Immunology $10,137 11 payments
  3. JOENJA $8,721 11 payments
  4. KINERET $3,147 2 payments
  5. RINVOQ $2,286 4 payments
  6. ACTIMMUNE $1,432 7 payments
  7. Xembify $560 20 payments
  8. DUPIXENT $502 11 payments
  9. GAMIFANT $466 5 payments
  10. NUCALA $380 7 payments
  11. Other $5,737 120 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

200 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record